Mural Oncology (MURA) Institutional Ownership $2.07 -0.01 (-0.48%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$2.10 +0.03 (+1.45%) As of 09/3/2025 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Mural Oncology (NASDAQ:MURA)CurrentInstitutional OwnershipPercentage80.21%Number ofInstitutional Buyers(last 12 months)26TotalInstitutional Inflows(last 12 months)$13.17MNumber ofInstitutional Sellers(last 12 months)17TotalInstitutional Outflows(last 12 months)$4.97M Get MURA Insider Trade Alerts Want to know when executives and insiders are buying or selling Mural Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data MURA Institutional Buying and Selling by Quarter Mural Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Soleus Capital Management L.P.1,323,877$3.27M0.2%N/A7.644% 8/15/2025 Rangeley Capital LLC46,513$115K0.1%N/A0.269% 8/15/2025 LMR Partners LLP516,417$1.28M0.0%N/A2.982% 8/15/2025 Acorn Capital Advisors LLC653,779$1.62M1.1%-48.5%3.775% 8/14/2025 Orbimed Advisors LLC588,800$1.45M0.0%N/A3.400% 8/14/2025 Raymond James Financial Inc.21,539$53K0.0%-59.2%0.124% 8/14/2025 RBF Capital LLC283,912$701K0.0%-10.2%1.639% 8/13/2025 Diametric Capital LP350,000$864K0.5%N/A2.020% 8/13/2025 F m Investments LLC77,567$192K0.0%N/A0.448% 8/13/2025 Quadrature Capital Ltd39,285$98K0.0%N/A0.227% Get the Latest News and Ratings for MURA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mural Oncology and its competitors with MarketBeat's FREE daily newsletter. 8/11/2025 Primecap Management Co. CA92,800$229K0.0%-32.7%0.536% 8/8/2025 Geode Capital Management LLC174,761$432K0.0%-4.7%1.009% 8/4/2025 Emerald Mutual Fund Advisers Trust77,567$192K0.0%N/A0.449% 6/27/2025 Goldman Sachs Group Inc.109,922$139K0.0%-5.1%0.636% 5/19/2025 Acorn Capital Advisors LLC1,269,715$1.60M1.0%-1.3%7.353% 5/16/2025 Goldman Sachs Group Inc.109,922$139K0.0%-5.1%0.637% 5/15/2025 Armistice Capital LLC1,722,000$2.17M0.0%+1.3%9.972% 5/15/2025 Solas Capital Management LLC887,995$1.12M0.6%-30.0%5.142% 4/29/2025 Concurrent Investment Advisors LLC22,500$28K0.0%N/A0.131% 2/18/2025 Alpine Global Management LLC80,964$261K0.1%-61.6%0.476% 2/17/2025 Squarepoint Ops LLC175,502$565K0.0%+1.4%1.031% 2/17/2025 Two Sigma Advisers LP26,000$84K0.0%N/A0.153% 2/17/2025 Two Sigma Investments LP65,150$210K0.0%+12.0%0.383% 2/17/2025 Prosight Management LP466,822$1.50M0.4%-18.2%2.743% 2/17/2025 Millennium Management LLC168,255$542K0.0%-11.1%0.989% 2/17/2025 Bridgeway Capital Management LLC29,300$94K0.0%N/A0.172% 2/17/2025 Acorn Capital Advisors LLC1,286,079$4.14M2.3%N/A7.556% 2/14/2025 Jane Street Group LLC21,117$68K0.0%N/A0.124% 2/14/2025 Northern Trust Corp39,966$129K0.0%+22.0%0.235% 2/14/2025 RBF Capital LLC338,669$1.09M0.1%-5.9%1.990% 2/14/2025 Price T Rowe Associates Inc. MD26,905$87K0.0%-28.6%0.158% 2/14/2025 Alpine Global Management LLC80,964$261K0.1%-61.6%0.476% 2/13/2025 Raymond James Financial Inc.56,176$181K0.0%N/A0.330% 2/13/2025 Renaissance Technologies LLC238,465$768K0.0%+17.4%1.401% 2/12/2025 Geode Capital Management LLC181,029$583K0.0%-4.7%1.064% 2/12/2025 Nicollet Investment Management Inc.94,737$305K0.1%-4.3%0.557% 2/11/2025 Virtu Financial LLC40,025$129K0.0%N/A0.235% 2/6/2025 Raymond James Financial Inc.56,176$181K0.0%N/A0.330% 1/13/2025 FNY Investment Advisers LLC15,000$48K0.0%-25.0%0.088% 11/16/2024 Geode Capital Management LLC190,056$595K0.0%+2.6%1.115% Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here11/15/2024 RBF Capital LLC359,900$1.13M0.1%-7.3%2.112% 11/15/2024 Point72 Asset Management L.P.108,715$340K0.0%N/A0.638% 11/15/2024 Centiva Capital LP203,706$638K0.0%-9.3%1.195% 11/15/2024 Point72 Asia Singapore Pte. Ltd.12,574$39K0.0%-52.8%0.074% 11/14/2024 Verition Fund Management LLC340,000$1.06M0.0%-33.4%1.996% 11/13/2024 BNP Paribas Financial Markets28,048$88K0.0%-71.0%0.165% 11/13/2024 FMR LLC20,580$64K0.0%+124.7%0.121% 11/9/2024 Primecap Management Co. CA140,045$438K0.0%-40.5%0.822% 11/8/2024 Commerce Bank12,423$39K0.0%N/A0.073% 9/16/2024 Cubist Systematic Strategies LLC31,243$98K0.0%N/A0.185% 9/16/2024 Point72 Asia Singapore Pte. Ltd.26,642$84K0.0%N/A0.157% 8/15/2024 Armistice Capital LLC1,688,000$5.30M0.1%N/A9.974% 8/15/2024 Point72 Asia Singapore Pte. Ltd.26,642$84K0.0%N/A0.157% 8/14/2024 Squarepoint Ops LLC167,644$526K0.0%N/A0.991% 8/14/2024 Cubist Systematic Strategies LLC31,243$98K0.0%N/A0.185% 8/13/2024 Canada Pension Plan Investment Board22,360$70K0.0%N/A0.132% 8/9/2024 Primecap Management Co. CA235,551$740K0.0%N/A1.392% 8/9/2024 Renaissance Technologies LLC232,100$729K0.0%N/A1.371% 8/9/2024 Dimensional Fund Advisors LP22,563$71K0.0%N/A0.133% 8/8/2024 Nicollet Investment Management Inc.98,016$308K0.1%N/A0.579% 8/6/2024 Acadian Asset Management LLC318,536$998K0.0%N/A1.882% 8/5/2024 BBR Partners LLC10,000$31K0.0%N/A0.059% 8/1/2024 Rhumbline Advisers10,786$34K0.0%N/A0.064% 7/9/2024 Harbor Capital Advisors Inc.36,769$115K0.0%N/A0.217% (Data available from 1/1/2016 forward) MURA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MURA shares? During the previous two years, 45 institutional investors and hedge funds held shares of Mural Oncology. The most heavily invested institutionals were Soleus Capital Management L.P. ($3.27M), Armistice Capital LLC ($2.17M), Acorn Capital Advisors LLC ($1.62M), Prosight Management LP ($1.50M), Orbimed Advisors LLC ($1.45M), LMR Partners LLP ($1.28M), and Solas Capital Management LLC ($1.12M).Learn more on Mural Oncology's institutional investors. What percentage of Mural Oncology's stock is owned by institutional investors? 80.21% of Mural Oncology's stock is owned by institutional investors. Learn more on MURA's institutional investor holdings. Which institutional investors have been buying Mural Oncology's stock? Of the 34 institutional investors that purchased Mural Oncology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($1.71M), Soleus Capital Management L.P. ($1.32M), Acorn Capital Advisors LLC ($1.29M), Orbimed Advisors LLC ($588.80K), LMR Partners LLP ($516.42K), Diametric Capital LP ($350K), and Acadian Asset Management LLC ($318.54K). How much institutional buying is happening at Mural Oncology? Institutional investors have bought a total of 4,826,639 shares in the last 24 months. This purchase volume represents approximately $13.17M in transactions. Which of Mural Oncology's major shareholders have been selling company stock? Of the 17 institutional investors that sold Mural Oncology's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Acorn Capital Advisors LLC ($632.30K), Solas Capital Management LLC ($381.01K), Alpine Global Management LLC ($259.25K), Verition Fund Management LLC ($170.85K), Primecap Management Co. CA ($140.51K), Prosight Management LP ($103.80K), and RBF Capital LLC ($81.73K). How much institutional selling is happening at Mural Oncology? Institutional investors have sold a total of 1,974,705 shares in the last 24 months. This volume of shares sold represents approximately $4.97M in transactions. Related Companies Forte Biosciences Institutional Ownership Cabaletta Bio Institutional Ownership Inhibikase Therapeutics Institutional Ownership Zentalis Pharmaceuticals Institutional Ownership Zura Bio Institutional Ownership Coherus Oncology Institutional Ownership Compugen Institutional Ownership Protalix BioTherapeutics Institutional Ownership Alpha Cognition Institutional Ownership Fate Therapeutics Institutional Ownership This page (NASDAQ:MURA) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored“Shadow Group” in Washington, DC Could Crash MarketNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Mural Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.